Cargando…

From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections

Antiviral restriction factors are cellular proteins that inhibit the entry, replication, or spread of viruses. These proteins are critical components of the innate immune system and function to limit the severity and host range of virus infections. Here we review the current knowledge on the mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemudupati, Mahesh, Kenney, Adam D., Bonifati, Serena, Zani, Ashley, McMichael, Temet M., Wu, Li, Yount, Jacob S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334645/
https://www.ncbi.nlm.nih.gov/pubmed/30290238
http://dx.doi.org/10.1016/j.bbamcr.2018.09.012
_version_ 1783387761987813376
author Chemudupati, Mahesh
Kenney, Adam D.
Bonifati, Serena
Zani, Ashley
McMichael, Temet M.
Wu, Li
Yount, Jacob S.
author_facet Chemudupati, Mahesh
Kenney, Adam D.
Bonifati, Serena
Zani, Ashley
McMichael, Temet M.
Wu, Li
Yount, Jacob S.
author_sort Chemudupati, Mahesh
collection PubMed
description Antiviral restriction factors are cellular proteins that inhibit the entry, replication, or spread of viruses. These proteins are critical components of the innate immune system and function to limit the severity and host range of virus infections. Here we review the current knowledge on the mechanisms of action of several restriction factors that affect multiple viruses at distinct stages of their life cycles. For example, APOBEC3G deaminates cytosines to hypermutate reverse transcribed viral DNA; IFITM3 alters membranes to inhibit virus membrane fusion; MXA/B oligomerize on viral protein complexes to inhibit virus replication; SAMHD1 decreases dNTP intracellular concentrations to prevent reverse transcription of retrovirus genomes; tetherin prevents release of budding virions from cells; Viperin catalyzes formation of a nucleoside analogue that inhibits viral RNA polymerases; and ZAP binds virus RNAs to target them for degradation. We also discuss countermeasures employed by specific viruses against these restriction factors, and mention secondary functions of several of these factors in modulating immune responses. These important examples highlight the diverse strategies cells have evolved to combat virus infections.
format Online
Article
Text
id pubmed-6334645
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-63346452020-03-01 From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections Chemudupati, Mahesh Kenney, Adam D. Bonifati, Serena Zani, Ashley McMichael, Temet M. Wu, Li Yount, Jacob S. Biochim Biophys Acta Mol Cell Res Review Antiviral restriction factors are cellular proteins that inhibit the entry, replication, or spread of viruses. These proteins are critical components of the innate immune system and function to limit the severity and host range of virus infections. Here we review the current knowledge on the mechanisms of action of several restriction factors that affect multiple viruses at distinct stages of their life cycles. For example, APOBEC3G deaminates cytosines to hypermutate reverse transcribed viral DNA; IFITM3 alters membranes to inhibit virus membrane fusion; MXA/B oligomerize on viral protein complexes to inhibit virus replication; SAMHD1 decreases dNTP intracellular concentrations to prevent reverse transcription of retrovirus genomes; tetherin prevents release of budding virions from cells; Viperin catalyzes formation of a nucleoside analogue that inhibits viral RNA polymerases; and ZAP binds virus RNAs to target them for degradation. We also discuss countermeasures employed by specific viruses against these restriction factors, and mention secondary functions of several of these factors in modulating immune responses. These important examples highlight the diverse strategies cells have evolved to combat virus infections. Elsevier B.V. 2019-03 2018-10-02 /pmc/articles/PMC6334645/ /pubmed/30290238 http://dx.doi.org/10.1016/j.bbamcr.2018.09.012 Text en © 2018 Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Chemudupati, Mahesh
Kenney, Adam D.
Bonifati, Serena
Zani, Ashley
McMichael, Temet M.
Wu, Li
Yount, Jacob S.
From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title_full From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title_fullStr From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title_full_unstemmed From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title_short From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections
title_sort from apobec to zap: diverse mechanisms used by cellular restriction factors to inhibit virus infections
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334645/
https://www.ncbi.nlm.nih.gov/pubmed/30290238
http://dx.doi.org/10.1016/j.bbamcr.2018.09.012
work_keys_str_mv AT chemudupatimahesh fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT kenneyadamd fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT bonifatiserena fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT zaniashley fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT mcmichaeltemetm fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT wuli fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections
AT yountjacobs fromapobectozapdiversemechanismsusedbycellularrestrictionfactorstoinhibitvirusinfections